文献速递瓣膜病与结构性心脏病冠心病

主动脉瓣置换术后二尖瓣狭窄的血流动力学与预后影响

Hemodynamics and Prognostic Impact of Concomitant Mitral Stenosis in Patients Undergoing Surgical or Transcatheter Aortic Valve Replacement for Aortic Stenosis.
PubMed 文献 · Circulation · 2019-10-07

本研究回顾性分析2008-2015年因重度主动脉瓣狭窄行外科或经导管主动脉瓣置换术的患者,以平均二尖瓣跨瓣压差≥4 mmHg定义二尖瓣狭窄。结果显示,合并二尖瓣狭窄的患者中,AVR后近半数二尖瓣面积增加,但仍有近半数(真性二尖瓣狭窄)面积≤2.0 cm²,且真性二尖瓣狭窄是全因死亡率的独立预测因子。

要点

  • AVR后二尖瓣面积平均增加0.26±0.59 cm²,55%患者增加,18%不变。
  • 真性二尖瓣狭窄(MVA≤2.0 cm²)是AVR后全因死亡的独立预测因子(aHR 1.88)。
  • 经导管AVR和 indexed stroke volume ≤45 mL/m² 与MVA增加独立相关。

核心结论

  • AVR后近半数重度主动脉瓣狭窄合并二尖瓣狭窄患者的二尖瓣面积改善。
  • 真性二尖瓣狭窄(MVA≤2.0 cm²)与AVR后 worse survival 独立相关。

研究设计与样本

  • 回顾性研究,纳入2008-2015年因重度主动脉瓣狭窄行外科AVR或经导管AVR的患者。
  • 190例合并二尖瓣狭窄患者(年龄76±9岁,42%男性),与362例无二尖瓣狭窄患者进行1:2匹配。

主要发现

  • 合并二尖瓣狭窄患者中,AVR后平均二尖瓣面积从2.00±0.50 cm²增至2.26±0.62 cm²(P<0.01)。
  • 二尖瓣面积增加105例(55%),不变34例(18%)。
  • 指数化每搏输出量≤45 mL/m²(OR 2.40;95%CI 1.15-5.01;P=0.020)和经导管AVR(OR 2.36;95%CI 1.17-4.77;P=0.017)与二尖瓣面积增加独立相关。
  • 107例显著二尖瓣狭窄(MVA≤2.0 cm²)中,AVR后52例(49%)面积增至>2.0 cm²(假性二尖瓣狭窄),55例(51%)仍≤2.0 cm²(真性二尖瓣狭窄)。
  • 中位随访2.9(0.7-4.9)年,真性二尖瓣狭窄是全因死亡的独立预测因子(调整后HR 1.88;95%CI 1.20-2.94;P<0.01)。

关键数值与推荐

  • 二尖瓣狭窄定义:平均二尖瓣跨瓣压差≥4 mmHg。
  • 根据二尖瓣面积(连续方程法)分层:>2.0 cm²或≤2.0 cm²。
  • 真性二尖瓣狭窄:AVR后MVA仍≤2.0 cm²;假性二尖瓣狭窄:AVR后MVA增至>2.0 cm²。

临床怎么用

  • 对重度主动脉瓣狭窄合并二尖瓣狭窄患者,AVR前应评估二尖瓣狭窄的可逆性。
  • AVR后MVA仍≤2.0 cm²(真性二尖瓣狭窄)提示预后较差,需加强随访。
  • 经导管AVR和低每搏输出量指数与MVA改善相关,可能影响治疗策略选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mitral stenosis frequently coexists in patients with severe aortic stenosis. Mitral stenosis severity evaluation is challenging in the setting of combined aortic stenosis and mitral stenosis because of hemodynamic interactions between the 2 valve lesions. The impact of aortic valve replacement (AVR) for severe aortic stenosis on mitral stenosis is unknown. This study aimed to assess the effect of AVR on mitral stenosis hemodynamics and the clinical outcomes of patients with severe aortic stenosis with and without mitral stenosis. METHODS: We retrospectively investigated patients who underwent surgical AVR or transcatheter AVR for severe aortic stenosis from 2008 to 2015. Mean transmitral gradient by Doppler echocardiography ≥4 mm Hg was identified as mitral stenosis; patients were then stratified according to mitral valve area (MVA, by continuity equation) as >2.0 cm2 or ≤2.0 cm2. MVA before and after AVR in patients with mitral stenosis were evaluated. Clinical outcomes of patients with and without mitral stenosis were compared using 1:2 matching for age, sex, left ventricular ejection fraction, method of AVR (surgical AVR versus transcatheter AVR) and year of AVR. RESULTS: Of 190 patients with severe aortic stenosis and mitral stenosis (age 76±9 years, 42% men), 184 were matched with 362 with severe aortic stenosis without mitral stenosis. Among all mitral stenosis patients, the mean MVA increased after AVR by 0.26±0.59 cm2 (from 2.00±0.50 to 2.26±0.62 cm2, P<0.01). MVA increased in 105 (55%) and remained unchanged in 34 (18%). Indexed stroke volume ≤45 mL/m2 (odds ratio [OR] 2.40; 95% CI, 1.15-5.01; P=0.020) and transcatheter AVR (OR, 2.36; 95% CI, 1.17-4.77; P=0.017) were independently associated with increase in MVA. Of 107 with significant mitral stenosis (MVA ≤2.0 cm2), MVA increased to >2.0 cm2 after AVR in 52 (49%, pseudo mitral stenosis) and remained ≤2.0 cm2 in 55 (51%, true mitral stenosis). During follow-up of median 2.9 (0.7-4.9) years, true mitral stenosis was an independent predictor of all-cause mortality (adjusted hazard ratio, 1.88; 95% CI, 1.20-2.94; P<0.01). CONCLUSIONS: MVA improved after AVR in nearly half of patients with severe aortic stenosis and mitral stenosis. MVA remained ≤2.0 cm2 (true mitral stenosis) in nearly half of patients with severe aortic stenosis and significant mitral stenosis; this was associated with worse survival among patients undergoing AVR for severe aortic stenosis.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Kato N, Padang R, Pislaru C, et al. Hemodynamics and Prognostic Impact of Concomitant Mitral Stenosis in Patients Undergoing Surgical or Transcatheter Aortic Valve Replacement for Aortic Stenosis. Circulation. 2019. PMID: 31589485. doi:10.1161/CIRCULATIONAHA.119.040679

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。